MassMutual Equity Opportunities Fund Class A
MFVAX
NASDAQ
| Weiss Ratings | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | MassMutual | |||
| Manager/Tenure (Years) | Donald J. Kilbride (8), John D. Linehan (8), Peter C. Fisher (0) | |||
| Website | http://www.massmutual.com/funds | |||
| Fund Information | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | MassMutual Equity Opportunities Fund Class A | |||
| Category | Large Blend | |||
| Sub-Category | US Equity Large Cap Blend | |||
| Prospectus Objective | Growth | |||
| Inception Date | May 01, 2000 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 250.00 | |||
| Front End Fee | 0.06 | |||
| Back End Fee | -- | |||
| Dividends and Shares | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.82% | |||
| Dividend | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.90% | |||
| Asset Allocation | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.22% | |||
| Stock | 99.77% | |||
| U.S. Stock | 93.27% | |||
| Non-U.S. Stock | 6.50% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.19% | |||
| 30-Day Total Return | 0.93% | |||
| 60-Day Total Return | 4.58% | |||
| 90-Day Total Return | 5.61% | |||
| Year to Date Total Return | 5.53% | |||
| 1-Year Total Return | 3.89% | |||
| 2-Year Total Return | 24.09% | |||
| 3-Year Total Return | 26.74% | |||
| 5-Year Total Return | 67.38% | |||
| Price | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $15.06 | |||
| 1-Month Low NAV | $14.61 | |||
| 1-Month High NAV | $15.11 | |||
| 52-Week Low NAV | $12.85 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $17.21 | |||
| 52-Week High Price (Date) | Oct 18, 2024 | |||
| Beta / Standard Deviation | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.77 | |||
| Standard Deviation | 13.34 | |||
| Balance Sheet | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 369.89M | |||
| Operating Ratios | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.26% | |||
| Turnover Ratio | 31.00% | |||
| Performance | MFVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 12.35% | |||
| Last Bear Market Total Return | -9.27% | |||